Neurokinin-1 antagonists for postoperative nausea and vomiting

Z Jin, N Daksla, TJ Gan - Drugs, 2021 - Springer
Postoperative nausea and vomiting (PONV) are the second most frequent adverse events
after surgery second only to postoperative pain. Despite the advances in antiemetics and …

Bioequivalence of HTX-019 (aprepitant IV) and fosaprepitant in healthy subjects: a phase I, open-label, randomized, two-way crossover evaluation

T Ottoboni, MR Keller, M Cravets… - Drug Design …, 2018 - Taylor & Francis
Introduction Fosaprepitant, an intravenous (IV) aprepitant prodrug for chemotherapy-
induced nausea and vomiting prophylaxis, is associated with systemic and infusion-site …

Comparative analgesic, hemodynamic, pain and duration of sensory and motor block effects of dexmedetomidine, granisetron, and nitroglycerin added to ropivacaine …

E Moshiri, H Modir, A Kamali, M Azami… - Medical Gas …, 2022 - journals.lww.com
Comparative analgesic, hemodynamic, pain and duration of sen... : Medical Gas Research
Comparative analgesic, hemodynamic, pain and duration of sensory and motor block effects of …

Should olanzapine be advocated over conventional anti-emetics for the prevention of chemotherapy-induced nausea and vomiting? An updated meta-analysis of …

EI Bahbah, AR Abdalla, K Abdelshafy… - Current Enzyme …, 2019 - ingentaconnect.com
Objective: The aim of this study is to synthesize the evidence about the efficacy of
Olanzapine for the prevention of CINV. Methods: A computer literature search of PubMed …

Therapeutic effect of low frequency electric pulse therapy on cisplatin-based chemotherapy-induced nausea and vomiting in patients with lung adenocarcinoma: A …

M Hu, L Yao, L Li, Y Han, Y Wang, Z Lei, H Wu - Medicine, 2022 - journals.lww.com
To explore the efficacy of low-frequency electric pulse therapy (LFEPT) combined with 2
antiemetics in the prevention and treatment of cisplatin-based chemotherapy-induced …

[PDF][PDF] Who can perform adjuvant chemotherapy treatment for gastric cancer? a multicenter retrospective overview of the current status in Korea

JS Min, CM Lee, SI Choi, KW Seo… - Journal of Gastric …, 2018 - synapse.koreamed.org
Purpose: To investigate the current status of adjuvant chemotherapy (AC) regimens in Korea
and the difference in efficacy of AC administered by surgical and medical oncologists in …

Farmacoterapia atual das náuseas e vômitos induzidos por antineoplásicos

AKF de Sousa Santos, AB de Gusmão… - Research, Society and …, 2021 - rsdjournal.org
Chemotherapy-induced nausea and vomiting (CINV) are common adverse drug reactions
with the use of anticancer drugs. Although there are advances in prophylactic therapy, the …

Anticancéreux hautement et modérément émétisants: place du rolapitant, un nouvel anti-NK-1, dans la prise en charge des nausées et vomissements chimio-induits.

V Launay-Vacher, JB Rey… - Journal de Pharmacie …, 2018 - search.ebscohost.com
English Background: Feared by the patients, chemotherapy induced nausea and vomiting
(CINV) jeopardize their health and quality of life. The combination of anti-5HT3, anti-NK1 …

A Comparative Study Between the Effects of Aprepitant and Ondansetron for the Prevention of Postoperative Nausea and Vomiting after Laparoscopic …

QA Wajid, S Ashraf, S Khan, H Khurshid… - Pakistan Journal of …, 2022 - pjmhsonline.com
Background: Postoperative nausea and vomiting is one of the most typical side effects
following surgery and anaesthesia (PONV). There has been a significant paradigm shift in …

The efficacy of aprepitant (NK-1 receptor antagonist) as prophylaxis for postoperative nausea and vomiting

M Akram, SP Bajwa, A Hussain, CA Safdar… - Pakistan Armed Forces …, 2020 - pafmj.org
Objective: To assess the effectiveness of Aprepitant (NK-1 receptor antagonist) for
prophylaxis of postoperative nausea and vomiting in middle aged female patients …